Founder, chairman Paul Bleicher leaving Phase Forward
Paul Bleicher, founder of Phase Forward Inc., will step down from his day-to-day operational responsibilities at the end of this month, including serving as chairman of the board. Bleicher will be replaced as chairman by CEO Robert Weiler, according to the company. Mass High Tech.
Nextrials expands its U.S. sales force
Nextrials Inc. announced the addition of regional directors of business development to its sales force. Scott Steward, based in Texas, and Virginia (Giga) Smith, based in North Carolina, join Denise Bowen in New Jersey and Alan Arroyo in California, giving the pharmaceutical, biotechnology and medical device industries experienced, local points of contact for Nextrials’ clinical trial management software and electronic data capture solution, Prism. Read the press release.
CRF Inc. strengthens clinical advisory board
CRF Inc., a provider of electronic patient-reported outcomes and wireless data collection solutions for life sciences, announced the expansion of its expert Clinical Advisory Board. To offer clients strategic regulatory and quality services in clinical research, CRF strengthens its Clinical Advisory Board with the addition of Halloran Consulting Group Inc. experts Laurie Halloran, president and CEO; Greg Dombal, VP of clinical and regulatory affairs; and Shaghig Palanjian, VP of consulting services. Read the press release.
Exco InTouch's electronic patient diary selected by Synairgen
Exco InTouch, a mobile messaging provider for the pharmaceutical industry, announces that its electronic patient-reported outcomes (ePRO) solutions have been selected by Synairgen, a drug discovery company focused on asthma and chronic obstructive pulmonary disease (COPD). Exco InTouch's short message service ePRO offerings will enable Synairgen to collect patient data in its second clinical study of inhaled interferon beta for asthma treatment. Read the press release.
Invivodata captures symptom relief data in endometriosis trial
Invivodata Inc., a provider of electronic patient reported outcomes (ePRO) solutions and services for global clinical research, announced that its DiaryPRO field-based ePRO system was used to capture important secondary efficacy endpoint data in Neurocrine Biosciences’ PETAL study, a Phase II clinical trial of its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis. Read the press release.
Good Products and Adlib Software partner for regulatory submissions
Good Products and Adlib Software announced an OEM partnership that will integrate Good Products' electronic document management system g-docs with Adlib Software's Express Server centralized PDF rendering tool. Using the new integrated system, pharmas will be able to store, manage and track regulatory documents and create high-quality regulatory submission-ready PDFs with bookmarks and hyperlinks. Read the press release.
________________________________
This story first appeared in eCliniqua,one of Bio-IT World’s free e-newsletters. Subscribe here.